GRAIL, Inc. (GRAL)
140.00
+2.63
(+1.91%)
USD |
NASDAQ |
Oct 13, 14:59
GRAIL Gross Profit Margin (Quarterly) : -30.61% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.61% |
| March 31, 2026 | -37.81% |
| December 31, 2025 | -33.70% |
| September 30, 2025 | -47.91% |
| June 30, 2025 | -62.93% |
| March 31, 2025 | -73.92% |
| December 31, 2024 | -41.74% |
| Date | Value |
|---|---|
| September 30, 2024 | -77.60% |
| June 30, 2024 | -56.03% |
| March 31, 2024 | -81.99% |
| December 31, 2023 | -61.50% |
| September 30, 2023 | -130.6% |
| June 30, 2023 | -108.3% |
| March 31, 2023 | -130.4% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -7.59% |
| Twist Bioscience Corp. | 52.76% |
| Prime Medicine, Inc. | -54.68% |
| Kailera Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.08% |
| Return on Assets | -13.86% |
| Return on Invested Capital | -15.67% |
| Profit Margin (Quarterly) | -246.7% |
| Operating Margin (Quarterly) | -332.0% |
| Return on Net Operating Assets | -19.54% |